BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,994 Cr | ₹4,061 Cr | ₹2,954 Cr | ₹1,853 Cr | ₹1,177 Cr |
What is the latest Cash Flow from Operating Activities ratio of BIOCON ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,994 Cr |
| Mar2025 | ₹4,061 Cr |
| Mar2024 | ₹2,954 Cr |
| Mar2023 | ₹1,853 Cr |
| Mar2022 | ₹1,177 Cr |
How is Cash Flow from Operating Activities of BIOCON Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,994 Cr | -50.90 | |
| Mar2025 | ₹4,061 Cr | 37.49 | |
| Mar2024 | ₹2,954 Cr | 59.45 | |
| Mar2023 | ₹1,853 Cr | 57.45 | |
| Mar2022 | ₹1,177 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹61,602.7 Cr | -4.1% | -8.1% | 4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -4.1% |
-8.1% |
4.3% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses